Table 2.
Procalcitonin: Overview of sensitivity and specificity values in different studies
| Author | Parameter | Cut-Off | Sensitivity | Specifity | p-value |
|---|---|---|---|---|---|
| Current study | Serum PCT | 0.5 ng/ml | 13 | 91 | < 0.001 |
| Synovial fluid PCT | 1.0 ng/mL | 87 | 0 | ||
| 5.0 ng/mL | 13 | 52 | |||
| Glehr et al. (2013) [8] | Serum PCT | 0.055 ng/mL | 81 | 54 | 0.038 |
| 0.36 ng/mL | 90 | 33 | |||
| Randau et al. (2014) [21] | Serum PCT | 46 ng/mL | 13 | 100 | |
| Sa-Ngasoong-song P et al. (2019) [15] | Serum PCT | 0.1 ng/mL | 65 | 92 | < 0.001 |
| 0.3 ng/mL | 50 | 100 | |||
| 0.5 ng/mL | 40 | 100 | |||
| Synovial fluid PCT | 0.08 ng/mL | 90 | 83 | < 0.001 | |
| 0.12 ng/mL | 80 | 92 | |||
| 0.16 ng/mL | 55 | 91 | |||
| Bottner et al. (2007) [40] | Serum PCT | 0.3 ng/mL | 33 | 98 | n.a. |